アレルギー性鼻炎の世界市場レポート 2025年

アレルギー性鼻炎の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.1％で184億9,000万米ドルに成長します。予測期間の成長は、予防治療への需要、高齢化、都市化、医療費支出に起因すると考えられます。予測期間の主な動向には、生物製剤とモノクローナル抗体、デジタルヘルスソリューション、アレルゲン回避戦略、小児アレルギー性鼻炎、アレルゲン検出技術などがあります。

高レベルの大気汚染と気候変動がアレルギー性鼻炎市場の成長を大きく促進すると予想されます。大気中の有害物質によって特徴づけられる大気汚染は、呼吸器の健康に悪影響を及ぼし、アレルギー性鼻炎の普及率上昇に寄与しています。気温や降水量が長期的に変化する気候変動は、花粉などのアレルゲンの頻度や強度を悪化させ、アレルギー性鼻炎の症状を悪化させる。この関連性は、呼吸器系の状態に影響を及ぼす環境要因に対する関心の高まりを強調しています。例えば、2024年8月、米国環境保護庁（EPA）は、2023年に米国全土で約6,600万トンの汚染物質が大気中に放出されたと報告しました。このような汚染レベルの上昇は、気候パターンの変化とともにアレルギー性鼻炎の発生率の上昇につながると予想され、それによって治療・管理ソリューション市場の成長を促進します。

アレルギー性鼻炎に対する副腎皮質ステロイド治療の増加は、アレルギー性鼻炎市場の成長を大きく促進すると予想されます。鼻腔内の炎症を抑えるために一般的に使用される副腎皮質ステロイドは、鼻づまり、くしゃみ、かゆみといったアレルギー性鼻炎の症状を緩和するのに効果的です。この治療法は、炎症を抑え、患者のQOL（生活の質）を向上させることができるため、人気が高まっています。例えば、2023年9月、米国臨床薬理治療学会は、経口コルチコステロイドの使用は米国で平均6.8％、台湾で17.5％、デンマークで2.2％であり、年間増加率は0.1％から0.17％であると報告しました。これらの処方の大部分は短期間のもので、一般的には呼吸器感染症のような自己限定的な症状の健康な成人に対するものでした。副腎皮質ステロイドの使用は増加の一途をたどっており、治療の選択肢を増やし患者の転帰を改善することで、アレルギー性鼻炎市場の拡大にさらに貢献するものと期待されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アレルギー性鼻炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のアレルギー性鼻炎市場：成長率分析
• 世界のアレルギー性鼻炎市場の実績：規模と成長, 2019-2024
• 世界のアレルギー性鼻炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界アレルギー性鼻炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアレルギー性鼻炎市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 季節のアレルギー性鼻炎
• 多年生アレルギー性鼻炎
• 職業的アレルギー性鼻炎
• 世界のアレルギー性鼻炎市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• コルチコステロイド
• 免疫療法
• 充血除去薬
• その他の治療法
• 世界のアレルギー性鼻炎市場テストによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚テスト
• IgE放射性アレルギー吸着剤（RAST）検査
• 完全血球計算
• 世界のアレルギー性鼻炎市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 鼻腔
• その他の投与経路
• 世界のアレルギー性鼻炎市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンラインストア
• 世界のアレルギー性鼻炎市場季節性アレルギー性鼻炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 花粉アレルギー
• カビアレルギー
• 世界のアレルギー性鼻炎市場通年性アレルギー性鼻炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ダニアレルギー
• ペットアレルギー
• カビアレルギー
• 世界のアレルギー性鼻炎市場職業性アレルギー性鼻炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学アレルゲン
• 生物学的アレルゲン

第7章 地域別・国別分析

• 世界のアレルギー性鼻炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアレルギー性鼻炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アレルギー性鼻炎市場：競合情勢
• アレルギー性鼻炎市場：企業プロファイル
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi-Aventis LLC. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• UCB S.A.
• Sun Pharmaceutical Industries Limited
• Menarini Group
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Cipla Limited
• Endo Pharmaceuticals Inc.
• Zydus Lifesciences Ltd.
• Lupin Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アレルギー性鼻炎市場2029：新たな機会を提供する国
• アレルギー性鼻炎市場2029：新たな機会を提供するセグメント
• アレルギー性鼻炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Allergic rhinitis is a condition characterized by an allergic response that triggers nasal inflammation due to allergens like pollen, dust, mold, or pet dander. This allergic reaction leads to symptoms such as sneezing, nasal congestion, an itchy nose, and a sore throat. The management of allergic rhinitis involves the use of a range of allergy medications available in different dosage forms to alleviate these bothersome symptoms.

Allergic rhinitis can be categorized into several types, including seasonal allergic rhinitis (SAR), perennial allergic rhinitis, and occupational allergic rhinitis. SAR is characterized by the rapid onset and resolution of symptoms, often associated with allergens like pollen. The treatments for allergic rhinitis encompass various options such as antihistamines, corticosteroids, immunotherapy, and decongestants. Diagnosis and evaluation may involve different tests like skin tests, IgE radioallergosorbent tests, and complete blood counts. These treatments are administered through various routes, including oral and nasal administration. Moreover, they are accessible through diverse distribution channels such as hospital pharmacies, retail pharmacies, and online stores.

The allergic rhinitis market research report is one of a series of new reports from The Business Research Company that provides allergic rhinitis market statistics, including allergic rhinitis industry global market size, regional shares, competitors with an allergic rhinitis market share, detailed allergic rhinitis market segments, market trends and opportunities and any further data you may need to thrive in the allergic rhinitis industry. This allergic rhinitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The allergic rhinitis market size has grown steadily in recent years. It will grow from $15.22 billion in 2024 to $15.74 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to allergen exposure, environmental changes, public awareness, incresing pollution, research and developments on allergic rhinitis, rising disposable incomes.

The allergic rhinitis market size is expected to see steady growth in the next few years. It will grow to $18.49 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to demand for preventive treatments, aging population, urbanization, health care spending. Major trends in the forecast period include biologics and monoclonal antibodies, digital health solutions, allergen avoidance strategies, pediatric allergic rhinitis, allergen detection technology.

High levels of air pollution and climate change are expected to significantly drive the growth of the allergic rhinitis market. Air pollution, characterized by harmful substances in the atmosphere, adversely affects respiratory health, contributing to the increasing prevalence of allergic rhinitis. Climate change, with its long-term alterations in temperature and precipitation, can exacerbate the frequency and intensity of allergens like pollen, which in turn worsens the symptoms of allergic rhinitis. This connection underscores the rising concern about environmental factors influencing respiratory conditions. For instance, in August 2024, the United States Environmental Protection Agency (EPA) reported that approximately 66 million tons of pollutants were released into the atmosphere across the U.S. in 2023. These elevated pollution levels, along with changing climate patterns, are expected to lead to higher incidences of allergic rhinitis, thereby driving the growth of the market for treatments and management solutions.

The increase in corticosteroid treatment for allergic rhinitis is expected to significantly drive the growth of the allergic rhinitis market. Corticosteroids, commonly used to reduce inflammation in the nasal passages, are effective in relieving the symptoms of allergic rhinitis, such as congestion, sneezing, and itching. This treatment approach has become increasingly popular due to its ability to control inflammation and improve the quality of life for patients. For example, in September 2023, the American Society for Clinical Pharmacology and Therapeutics reported that oral corticosteroid use averaged 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark, with annual increases ranging from 0.1% to 0.17%. The majority of these prescriptions were for short bursts, typically for healthy adults with self-limited conditions like respiratory infections. As the use of corticosteroids continues to rise, it is expected to further contribute to the expansion of the allergic rhinitis market by enhancing treatment options and improving patient outcomes.

Prominent players within the allergic rhinitis market are actively engaged in the development of cutting-edge medications to maintain their market presence. For instance, in August 2022, Hikma Pharmaceuticals PLC, a pharmaceutical company based in the UK, and Glenmark Specialty S.A., a pharmaceutical company headquartered in Switzerland, received approval from the United States Food and Drug Administration (FDA), a federal agency based in the US, for their product known as Ryaltris. Ryaltris represents the first fixed-dose combination medication designed to alleviate both nasal and ocular symptoms of seasonal allergic rhinitis. It is conveniently administered as a nasal spray for adult and pediatric patients aged 12 and above. Notably, the relief from nasal symptoms begins within 15 minutes of the initial dose.

In January 2022, Glenmark Specialty S.A., a pharmaceutical company headquartered in Switzerland, established a partnership with Lotus International Pte. Ltd., a pharmaceutical company based in Singapore. Through this collaboration, Glenmark is set to introduce Ryaltris, an innovative nasal spray designed for allergic rhinitis treatment, into the markets of Singapore, Hong Kong, and Vietnam. Under this arrangement, Glenmark will be responsible for the manufacturing and supply of Ryaltris, while Lotus will oversee the commercialization of Ryaltris in these regions.

Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the allergic rhinitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allergic rhinitis market consists of revenues earned by entities by providing treatments such as alternative therapies, surgeries and lifestyle modifications. The market value includes the value of related goods sold by the service provider or included within the service offering. The allergic rhinitis market also includes sales of allergy pills and injections that are used for the treatment of the disease. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allergic Rhinitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergic rhinitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allergic rhinitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allergic rhinitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
• 2) By Treatment: Antihistamines; Corticosteroids; Immunotherapy; Decongestants; Other Treatments
• 3) By Test: Skin Test; IgE Radioallergosorbent (RAST) Test; Complete Blood Count
• 4) By Route Of Administration: Oral; Nasal; Other Route Of Administration
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores
• Subsegments:
• 1) By Seasonal Allergic Rhinitis: Pollen Allergy; Mold Allergy
• 2) By Perennial Allergic Rhinitis: Dust Mite Allergy; Pet Allergy; Mold Allergy
• 3) By Occupational Allergic Rhinitis: Chemical Allergens; Biological Allergens
• Companies Mentioned: Merck and Co. Inc.; Bayer AG; Novartis AG; Sanofi-Aventis LLC.; AstraZeneca PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Allergic Rhinitis Market Characteristics

3. Allergic Rhinitis Market Trends And Strategies

4. Allergic Rhinitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Allergic Rhinitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Allergic Rhinitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Allergic Rhinitis Market Growth Rate Analysis
• 5.4. Global Allergic Rhinitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Allergic Rhinitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Allergic Rhinitis Total Addressable Market (TAM)

6. Allergic Rhinitis Market Segmentation

• 6.1. Global Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis
• 6.2. Global Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Corticosteroids
• Immunotherapy
• Decongestants
• Other Treatments
• 6.3. Global Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Test
• IgE Radioallergosorbent (RAST) Test
• Complete Blood Count
• 6.4. Global Allergic Rhinitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Nasal
• Other Route Of Administration
• 6.5. Global Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• 6.6. Global Allergic Rhinitis Market, Sub-Segmentation Of Seasonal Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pollen Allergy
• Mold Allergy
• 6.7. Global Allergic Rhinitis Market, Sub-Segmentation Of Perennial Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dust Mite Allergy
• Pet Allergy
• Mold Allergy
• 6.8. Global Allergic Rhinitis Market, Sub-Segmentation Of Occupational Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Allergens
• Biological Allergens

7. Allergic Rhinitis Market Regional And Country Analysis

• 7.1. Global Allergic Rhinitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Allergic Rhinitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Allergic Rhinitis Market

• 8.1. Asia-Pacific Allergic Rhinitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Allergic Rhinitis Market

• 9.1. China Allergic Rhinitis Market Overview
• 9.2. China Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Allergic Rhinitis Market

• 10.1. India Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Allergic Rhinitis Market

• 11.1. Japan Allergic Rhinitis Market Overview
• 11.2. Japan Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Allergic Rhinitis Market

• 12.1. Australia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Allergic Rhinitis Market

• 13.1. Indonesia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Allergic Rhinitis Market

• 14.1. South Korea Allergic Rhinitis Market Overview
• 14.2. South Korea Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Allergic Rhinitis Market

• 15.1. Western Europe Allergic Rhinitis Market Overview
• 15.2. Western Europe Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Allergic Rhinitis Market

• 16.1. UK Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Allergic Rhinitis Market

• 17.1. Germany Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Allergic Rhinitis Market

• 18.1. France Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Allergic Rhinitis Market

• 19.1. Italy Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Allergic Rhinitis Market

• 20.1. Spain Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Allergic Rhinitis Market

• 21.1. Eastern Europe Allergic Rhinitis Market Overview
• 21.2. Eastern Europe Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Allergic Rhinitis Market

• 22.1. Russia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Allergic Rhinitis Market

• 23.1. North America Allergic Rhinitis Market Overview
• 23.2. North America Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Allergic Rhinitis Market

• 24.1. USA Allergic Rhinitis Market Overview
• 24.2. USA Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Allergic Rhinitis Market

• 25.1. Canada Allergic Rhinitis Market Overview
• 25.2. Canada Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Allergic Rhinitis Market

• 26.1. South America Allergic Rhinitis Market Overview
• 26.2. South America Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Allergic Rhinitis Market

• 27.1. Brazil Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Allergic Rhinitis Market

• 28.1. Middle East Allergic Rhinitis Market Overview
• 28.2. Middle East Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Allergic Rhinitis Market

• 29.1. Africa Allergic Rhinitis Market Overview
• 29.2. Africa Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Allergic Rhinitis Market Competitive Landscape And Company Profiles

• 30.1. Allergic Rhinitis Market Competitive Landscape
• 30.2. Allergic Rhinitis Market Company Profiles
  • 30.2.1. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi-Aventis LLC. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Allergic Rhinitis Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Viatris Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Regeneron Pharmaceuticals Inc.
• 31.6. UCB S.A.
• 31.7. Sun Pharmaceutical Industries Limited
• 31.8. Menarini Group
• 31.9. Perrigo Company plc
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Hikma Pharmaceuticals PLC
• 31.12. Cipla Limited
• 31.13. Endo Pharmaceuticals Inc.
• 31.14. Zydus Lifesciences Ltd.
• 31.15. Lupin Limited

32. Global Allergic Rhinitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allergic Rhinitis Market

34. Recent Developments In The Allergic Rhinitis Market

35. Allergic Rhinitis Market High Potential Countries, Segments and Strategies

• 35.1 Allergic Rhinitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Allergic Rhinitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Allergic Rhinitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer